Sjoerd T Ligthart
Overview
Explore the profile of Sjoerd T Ligthart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ligthart S, Coumans F, Bidard F, Simkens L, Punt C, de Groot M, et al.
PLoS One
. 2013 Jul;
8(6):e67148.
PMID: 23826219
Background: Presence of circulating tumor cells (CTC) in patients with metastatic breast, colorectal and prostate cancer is indicative for poor prognosis. An automated CTC (aCTC) algorithm developed previously to eliminate...
2.
Coumans F, Ligthart S, Terstappen L
Transl Oncol
. 2013 Jan;
5(6):486-91.
PMID: 23323160
The presence of circulating tumor cells (CTCs) in the blood of cancer patients may guide the use of therapy. We investigated how to evaluate a reduction in the number of...
3.
Coumans F, Ligthart S, Uhr J, Terstappen L
Clin Cancer Res
. 2012 Sep;
18(20):5711-8.
PMID: 23014524
Purpose: Presence of circulating tumor cells (CTC) in metastatic carcinoma is associated with poor survival. Phenotyping and genotyping of CTC may permit "real-time" treatment decisions, provided CTCs are available for...
4.
Scholtens T, Schreuder F, Ligthart S, Swennenhuis J, Greve J, Terstappen L
Cytometry A
. 2011 Dec;
81(2):138-48.
PMID: 22170812
Presence of circulating tumor cells (CTC), as detected by the CellSearch System, in patients with metastatic carcinomas is associated with poor survival prospects. CellTracks TDI, a dedicated image cytometer, was...
5.
Ligthart S, Coumans F, Attard G, Mulick Cassidy A, de Bono J, Terstappen L
PLoS One
. 2011 Nov;
6(11):e27419.
PMID: 22087312
Circulating tumour cells (CTC) in patients with metastatic carcinomas are associated with poor survival and can be used to guide therapy. Classification of CTC however remains subjective, as they are...
6.
Scholtens T, Schreuder F, Ligthart S, Swennenhuis J, Tibbe A, Greve J, et al.
Cytometry A
. 2011 Feb;
79(3):203-13.
PMID: 21337699
Characterization of rare cells usually requires high sensitivity quantification of multiple parameters. Detection of morphological features of these cells is highly desired when routinely identifying circulating tumor cells (CTC) in...